Drugs Approved by the FDA

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Phone-Poulenc Rorer
Approval Status: Approved October 1997
Treatment for: allergic rhinitis

General Information

Nasacort (R) AQ (triamcinolone acetonide) has been approved by the U.S. Food and Drug Administration (FDA) for use the treatment of nasal symptoms of seasonal and perennial allergic rhinitis in children aged 6-11. Nasacort in currently available in the U.S. for adults and children aged 12 years and older.